How much revenue did Co-Diagnostics generate this year?
Co-Diagnostics has achieved a revenue of 1.63 M USD this year.
Co-Diagnostics Revenue 2024
Co-Diagnostics Revenue
1.63 M USD
Co-Diagnostics Dividend yield
Ticker
CODX
ISIN
US1897631057
WKN
A2DU6V
In 2024, Co-Diagnostics's sales reached 1.63 M USD, a -76.15% difference from the 6.81 M USD sales recorded in the previous year.
The Co-Diagnostics Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 47.68 | 5,51 |
| 2025e | 1.53 | 171,71 |
| 2024e | 1.63 | 161,67 |
| 2023 | 6.81 | 38,57 |
| 2022 | 34.22 | 83,99 |
| 2021 | 97.89 | 88,17 |
| 2020 | 74.55 | 77,75 |
| 2019 | 0.21 | 47,62 |
| 2018 | 0.04 | 75,00 |
| 2017 | 0.01 | 100,00 |
| 2016 | - | - |
| 2015 | 0.01 | 100,00 |
| 2014 | - | - |
Co-Diagnostics Aktienanalyse
What does Co-Diagnostics do?
Co-Diagnostics Inc is a company specializing in the development and marketing of innovative diagnostic tests and products. The company is headquartered in Salt Lake City, Utah, USA, and is listed on the NASDAQ under the ticker symbol "CODX". Co-Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Co-Diagnostics's Sales Figures
The sales figures of Co-Diagnostics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Co-Diagnostics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Co-Diagnostics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Co-Diagnostics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Co-Diagnostics Stock
How much was the turnover of the company Co-Diagnostics compared to the previous year?
The revenue of Co-Diagnostics has increased by -76.15% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Co-Diagnostics?
The revenue of Co-Diagnostics is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Co-Diagnostics measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Co-Diagnostics so important for investors?
The revenue of Co-Diagnostics is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Co-Diagnostics pay?
Over the past 12 months, Co-Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Co-Diagnostics is expected to pay a dividend of 0 USD.
What is the dividend yield of Co-Diagnostics?
The current dividend yield of Co-Diagnostics is .
When does Co-Diagnostics pay dividends?
Co-Diagnostics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Co-Diagnostics?
Co-Diagnostics paid dividends every year for the past 0 years.
What is the dividend of Co-Diagnostics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Co-Diagnostics located?
Co-Diagnostics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Co-Diagnostics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Co-Diagnostics from 6/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/2/2024.
When did Co-Diagnostics pay the last dividend?
The last dividend was paid out on 6/2/2024.
What was the dividend of Co-Diagnostics in the year 2023?
In the year 2023, Co-Diagnostics distributed 0 USD as dividends.
In which currency does Co-Diagnostics pay out the dividend?
The dividends of Co-Diagnostics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Co-Diagnostics
Our stock analysis for Co-Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Co-Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Co-Diagnostics Revenue
- Co-Diagnostics Net Income
- Co-Diagnostics P/E
- Co-Diagnostics P/S
- Co-Diagnostics EBIT
- Co-Diagnostics Dividend
- Co-Diagnostics Stocks
- Co-Diagnostics Market capitalization
- Co-Diagnostics Debt
- Co-Diagnostics Liabilities
- Co-Diagnostics Equity
- Co-Diagnostics AAQS
- Co-Diagnostics Employees
- Co-Diagnostics ROE
- Co-Diagnostics ROA
- Co-Diagnostics ROCE
